Literature DB >> 4403305

Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor".

J W Kebabian, G L Petzold, P Greengard.   

Abstract

An adenylate cyclase that is activated specifically by low concentrations of dopamine has been demonstrated in homogenates of caudate nucleus of rat brain. A half-maximal increase in the activity of the enzyme occurred in the presence of 4 muM dopamine. Concentrations of dopamine as low as 0.3 muM stimulated the activity of the enzyme. The adenylate cyclase activity of the homogenates was also stimulated by low concentrations of apomorphine, a substance known to mimic the physiological and pharmacological effects of dopamine. The stimulatory effect of dopamine was blocked by low concentrations of either haloperidol or chlorpromazine, agents known to block the actions of dopamine in mammalian brain. The results suggest that dopamine-sensitive adenylate cyclase may be the receptor for dopamine in mammalian brain. The isolation of this enzyme from caudate nucleus should facilitate the search for new therapeutic agents useful in the treatment of extrapyramidal diseases.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4403305      PMCID: PMC426888          DOI: 10.1073/pnas.69.8.2145

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

Review 1.  Generation of slow inhibitory and excitatory postsynaptic potentials.

Authors:  B Libet
Journal:  Fed Proc       Date:  1970 Nov-Dec

2.  Interactions between the catecholamines and ganglionic stimulating agents in sympathetic ganglia.

Authors:  W C De Groat; R L Volle
Journal:  J Pharmacol Exp Ther       Date:  1966-11       Impact factor: 4.030

3.  Evidence for dopamine receptor stimulation by apomorphine.

Authors:  N E Andén; A Rubenson; K Fuxe; T Hökfelt
Journal:  J Pharm Pharmacol       Date:  1967-09       Impact factor: 3.765

4.  Direct chemical stimulation of dopaminergic mechanisms in the neostriatum of the rat.

Authors:  U Ungerstedt; L L Butcher; S G Butcher; N E Andén; K Fuxe
Journal:  Brain Res       Date:  1969-07       Impact factor: 3.252

5.  Functional role of the nigro-neostriatal dopamine neurons.

Authors:  N E Andén; A Dahlström; K Fuxe; K Larsson
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1966

6.  Gamma-hydroxybutyrate-induced increase in brain dopamine: localization by fluorescence microscopy.

Authors:  G K Aghajanian; R H Roth
Journal:  J Pharmacol Exp Ther       Date:  1970-10       Impact factor: 4.030

7.  Caudate nucleus neurones: correlation of the effects of substantia nigra stimulaton with iontophoretic dopamine.

Authors:  J D Connor
Journal:  J Physiol       Date:  1970-07       Impact factor: 5.182

8.  Anesthesia and the responsiveness of individual neurons of the caudate nucleus of the cat to acetylcholine, norepinephrine and dopamine administered by microelectrophoresis.

Authors:  F E Bloom; E Costa; G C Salmoiraghi
Journal:  J Pharmacol Exp Ther       Date:  1965-11       Impact factor: 4.030

Review 9.  Dopamine (3-hydroxytyramine) and brain function.

Authors:  O Hornykiewicz
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

10.  Adenosine 3',5'-monophosphate in nervous tissue: increase associated with synaptic transmission.

Authors:  D A McAfee; M Schorderet; P Greengard
Journal:  Science       Date:  1971-03-19       Impact factor: 47.728

View more
  163 in total

1.  Synaptic transmission: a story of successive successes.

Authors:  G Stock
Journal:  J Mol Med (Berl)       Date:  2001-07       Impact factor: 4.599

Review 2.  Neurochemistry and behavior in man.

Authors:  G S Omenn
Journal:  West J Med       Date:  1976-12

3.  On the receptors which mediate the hyperpolarization of salivary gland cells of Nauphoeta cinerea Olivier.

Authors:  B L Ginsborg; C R House; E M Silinsky
Journal:  J Physiol       Date:  1976-11       Impact factor: 5.182

4.  Inhibition of dopamine-sensitive adenylate cyclase in rat basal ganglia and other hormone sensitive adenylate cyclase systems by neuroleptic drugs.

Authors:  R Miller
Journal:  Br J Pharmacol       Date:  1975-03       Impact factor: 8.739

5.  Use of siRNA in knocking down of dopamine receptors, a possible therapeutic option in neuropsychiatric disorders.

Authors:  Mohammad-Reza Noori-Daloii; Majid Mojarrad; Ali Rashidi-Nezhad; Majid Kheirollahi; Ali Shahbazi; Mehdi Khaksari; Asghar Korzebor; Ali Goodarzi; Maryam Ebrahimi; Ali Reza Noori-Daloii
Journal:  Mol Biol Rep       Date:  2011-06-03       Impact factor: 2.316

6.  Ontogenesis of neostriatal cholinergic neurones in the rat and development of their sensitivity to neuroleptic drugs.

Authors:  P G Guyenet; J C Beaujouan; J Glowinski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

7.  Lack of involvement of dopaminergic and GABA neurones in the inhbitory effect of harmaline on the activity of striatal cholinergic neurones in the rat.

Authors:  F Javoy; C Euvrard; A Herbet; J Bockaert; A Enjalbert; Y Agid; J Glowinski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-04       Impact factor: 3.000

8.  Paul Greengard: Signals underlying moods, addictions, and brain disorders.

Authors:  Sandeep Ravindran
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-21       Impact factor: 11.205

9.  What dopamine does in the brain.

Authors:  Solomon H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-21       Impact factor: 11.205

10.  Cerebrospinal fluid cyclic AMP and acid monoamine metabolites following probenecid: studies in psychiatric patients.

Authors:  M B Bowers; R E Study
Journal:  Psychopharmacology (Berl)       Date:  1979-03-29       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.